Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 06.01.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
06.01.Alcadon Holding AB: Fredrik Valentin assumes the position as President and CEO of Alcadon Group AB23As previously communicated, Fredrik Valentin will assume the position as President and CEO of Alcadon Group AB tomorrow, 7 January 2025. Pierre Fors will thus step down from his role as acting President...
► Artikel lesen
06.01.Icelandair Group hf.: 4.7 million passengers in 2024 - record load factor in December71In the full year of 2024, Icelandair transported a record of 4.7 million passengers, 9% more than in 2023. In December, the Company transported 312 thousand passengers, an 18% increase compared to December...
► Artikel lesen
06.01.Forsys Metals Corp: Forsys Reaches Agreement to Purchase Farm Namibplaas Portion-1 on Exclusive Prospecting Licence (EPL-3638)158TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) ("Forsys" or the "Company") is pleased to announce that its wholly-owned subsidiary Valencia Uranium...
► Artikel lesen
06.01.DBM Global Inc. Announces Election of Mark Koolis as CFO52PHOENIX, Jan. 06, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBM") announces the election of new Chief Financial Officer (CFO) - Mark Koolis. Former CFO Michael R. Hill has taken a different position...
► Artikel lesen
06.01.GCC, S.A.B. de C.V.: GCC Closes Strategic Aggregates Acquisitions140CHIHUAHUA, Mexico, Jan. 06, 2025 (GLOBE NEWSWIRE) -- GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, today announced the acquisition of...
► Artikel lesen
06.01.Aclaris Therapeutics, Inc.: Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)91WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the "Company" or "Aclaris"), a clinical-stage biopharmaceutical company focused on developing novel drug candidates...
► Artikel lesen
06.01.Denali Therapeutics Inc.: Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial100Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not met at 24 weeksOverall, DNL343 was found to be safe...
► Artikel lesen
06.01.APA Corporation Announces Executive Leadership and Corporate Officer Updates; Executive Vice President, Operations Clay Bretches to Retire, Kimberly Warnica joins Company as Executive Vice President and Chief Legal Officer68HOUSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) today announced key updates to its executive leadership and corporate officers. Clay Bretches, executive vice president, Operations...
► Artikel lesen
06.01.Stryker Corporation: Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment69Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of...
► Artikel lesen
06.01.Avadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)64DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee...
► Artikel lesen
06.01.CytomX Therapeutics Inc.: CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update99- Encouraging progress supports near-term focus on lead wholly-owned program, CX-2051 (EpCAM PROBODY® ADC). Initial Phase 1a clinical data in advanced metastatic colorectal cancer (CRC) are anticipated...
► Artikel lesen
06.01.Symbotic Inc.: Symbotic Names Dr. James Kuffner as Chief Technology Officer203WILMINGTON, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the appointment of Dr. James Kuffner...
► Artikel lesen
06.01.Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)47WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations...
► Artikel lesen
06.01.ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease76Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with standard of care and a more favorable safety profile Conducted...
► Artikel lesen
06.01.Qomolangma Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination35NEW YORK, NY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Qomolangma Acquisition Corp. (NASDAQ: QOMO) ("Qomolangma" or the "Company"), a publicly-traded special purpose acquisition company, today announced...
► Artikel lesen
06.01.Nobel Resources Corp.: Nobel Resources Signs Option Agreements to Acquire 100% Interest in Chilean Copper Portfolio in Antofagasta Region, Chile117TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Nobel Resources Corp. (TSX - V: NBLC) (the "Company" or "Nobel") is pleased to announce it has entered into binding agreements pursuant to which it can acquire...
► Artikel lesen
06.01.BioPorto A/S: Preliminary Financial Figures for the 2024 Fiscal Year43January 6, 2025 Announcement no. 01 Preliminary Financial Figures for the 2024 Fiscal Year COPENHAGEN, DENMARK, January 6, 2025, (GLOBE NEWSWIRE) - BioPorto A/S CVR-no. 17500317 (BioPorto or Company)...
► Artikel lesen
06.01.Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering96Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing...
► Artikel lesen
06.01.CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split115SOUTH SAN FRANSCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the...
► Artikel lesen
06.01.Harbert Management Corporation's South Bay team announces closing on The Whitford of Dublin253DUBLIN, Calif. and DALLAS and BIRMINGHAM, Ala., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Harbert Management Corporation's ("HMC") South Bay investment team ("Harbert South Bay" or the "Team") announced it...
► Artikel lesen
Seite:  Weiter >>